- Coming Soon
- About Head
Cancer research is one of the strategic R&D programs at KAIMRC. The development of an effective plan for the implementation of precision medicine, and specifically for Innovations in Cancer will require the establishment of an integrated and coordinated team of cancer researchers and oncologists. Our goal is to set up targeted cancer R&D programs covering primarily breast, colorectal, leukemia, lymphoma and thyroid cancer.
The program will encompass areas such as Therapeutic vaccinations in cancer, Immune gene therapy for cancer as well as the development of new diagnostics and other therapeutic solutions.
The program is planned to culminate in the development of commercial opportunities with the pharmaceutical industry at two specific levels; (1) Access to the state-of-the-art medicines, such as Chimeric Antigen Receptor (CAR) based cellular therapies, novel vaccination strategies, etc. (2) Actual development of new therapeutic strategies. Depending on the local needs and interests.